canrenone has been researched along with Hypertension in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (45.83) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 1 (4.17) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Armanini, D; Boscaro, M; Sabbadin, C | 1 |
| Avataneo, V; Bertello, C; Buffolo, F; Burrello, J; D'Avolio, A; Mengozzi, G; Monticone, S; Mulatero, P; Pecori, A; Rabbia, F; Rumbolo, F; Veglio, F | 1 |
| Blaich, C; Hoffmann, F; Johannsen, JO; Müller, C; Reuter, H; Streichert, T; Wiesen, MHJ | 1 |
| D'Angelo, A; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Zoppi, A | 1 |
| Armanini, D; Bordin, L; Clari, G; Donà, G; Sabbadin, C | 1 |
| Bagrov, AY; Bagrov, KA; Emelianov, IV; Fedorova, OV; Frolova, EV; Grigorova, YN; Juhasz, O; Konradi, AO; Lakatta, EG; Marshall, CA; Wei, W | 1 |
| Bestetti, A; D'Avino, M; Derosa, G; Felis, S; Gaudio, G; Guasti, L; Maffioli, P; Mugellini, A; Sala, C; Sarzani, R; Vanasia, M; Vulpis, V | 1 |
| Camilla, R; Einaudi, S; Monticone, S; Mulatero, P; Mussa, A; Porta, F; Tessaris, D; Verna, F | 1 |
| Barlocco, E; Bertolini, A; Grandi, AM; Guasti, L; Imperiale, D; Santillo, R; Venco, A | 1 |
| Liedholm, H; Lindholm, L; Melander, A; Thulin, T; Wåhlin-Boll, E | 1 |
| Anderton, JL; Bell, GM; Fananapazir, L | 1 |
| Bianchi, G; Duzzi, L; Ferrandi, M; Ferrari, P; Minotti, E | 1 |
| Claire, M; Corvol, P; Menard, J; Michaud, A; Rafestin-Oblin, ME; Roth-Meyer, C | 1 |
| Berthaux, P; Forette, B; Forette, F; Henry, JF; Hervy, MP | 1 |
| al Karadaghi, P; MacArthy, P; Preuss, HG; Yousufi, A | 1 |
| Clough, DL; Haddy, FJ; Pamnani, MB; Whitehorn, WV | 1 |
| Christiaens, L; Fenghe, D; Genard, P; Krzesinski, JM; Lomba-Pignon, MR; Palem-Vliers, M; Pequeux-Bar, ML; Rorive, G | 1 |
| Garay, R; Meyer, P; Rosati, C | 1 |
| Haddy, FJ; Pamnani, MB | 1 |
| de Mendonça, M; Devynck, MA; Garay, R; Grichois, ML; Meyer, P; Pernollet, MG; Trouillet-Thormann, B; Wauquier, I | 1 |
| Abitbol, JP; Garay, R; Girerd, X; Hannaert, P; Laurent, S; Safar, M | 1 |
| Boero, R; Deabate, MC; Guarena, C; Piccoli, G; Quarello, F; Rolando, B; Rosati, C | 1 |
| Boero, R; Deabate, MC; Forneris, G; Guarena, C; Piccoli, G; Quarello, F; Rosati, C | 1 |
| de Mendonça, M; Devynck, MA; Garay, RP; Grichois, ML; Meyer, P; Pernollet, MG; Thormann, B; Wauquier, I | 1 |
4 review(s) available for canrenone and Hypertension
| Article | Year |
|---|---|
Spirolactones: clinical and pharmacologic studies.
Topics: Aldosterone; Animals; Binding, Competitive; Canrenoic Acid; Canrenone; Diuresis; Humans; Hyperaldosteronism; Hypertension; In Vitro Techniques; Kidney; Mineralocorticoid Receptor Antagonists; Pregnadienes; Protein Binding; Rats; Receptors, Cell Surface; Spironolactone | 1977 |
[Arguments for the existence of an endogenous inhibitor of renal Na-K ATPase with steroid structure and natriuretic action].
Topics: Animals; Canrenone; Hypertension; Kidney; Natriuresis; Rabbits; Rats; Sodium-Potassium-Exchanging ATPase | 1990 |
Na+ transport in primary hypertension.
Topics: Animals; Biological Transport, Active; Canrenone; Cell Membrane; Humans; Hypertension; Ion Channels; Natriuretic Agents; Potassium; Rats; Rats, Inbred SHR; Sodium | 1986 |
Pharmacologic agents for the in vivo detection of vascular sodium transport defects in hypertension.
Topics: Amiloride; Animals; Biological Transport, Active; Canrenone; Humans; Hypertension; Ion Channels; Ouabain; Sodium; Sodium-Potassium-Exchanging ATPase; Vascular Diseases | 1987 |
5 trial(s) available for canrenone and Hypertension
| Article | Year |
|---|---|
Comparative effect of canrenone or hydrochlorothiazide addition to valsartan/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Canrenone; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Prospective Studies; Tetrazoles | 2014 |
Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Canrenone; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Italy; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Sodium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome | 2017 |
Aldosterone antagonist improves diastolic function in essential hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Canrenone; Diastole; Drug Administration Schedule; Echocardiography; Heart; Heart Rate; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Prospective Studies; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Comparison of single and divided daily dose spironolactone in the control of hypertension.
Topics: Adolescent; Adult; Aged; Blood Pressure; Canrenone; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Pregnadienes; Spironolactone | 1981 |
[The treatment of hypertension in the elderly using a beta-blocker: acebutolol (author's transl)].
Topics: Acebutolol; Aged; Canrenone; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Renin; Sulfonamides | 1979 |
15 other study(ies) available for canrenone and Hypertension
| Article | Year |
|---|---|
Primary aldosteronism: considerations about the evaluation of the aldosterone to renin ratio during canrenone treatment.
Topics: Aldosterone; Antihypertensive Agents; Canrenone; Diagnostic Techniques, Endocrine; Duration of Therapy; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System; Reproducibility of Results | 2021 |
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Topics: Adolescent; Adrenalectomy; Adult; Aged; Aldosterone; Canrenone; Cohort Studies; False Negative Reactions; Female; Guidelines as Topic; Humans; Hyperaldosteronism; Hypertension; Male; Mass Screening; Medication Adherence; Middle Aged; Mineralocorticoid Receptor Antagonists; Potassium; Prospective Studies; Renin; Reproducibility of Results; Young Adult | 2021 |
Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
Topics: Amlodipine; Antihypertensive Agents; Canrenone; Carbon Isotopes; Chromatography, High Pressure Liquid; Deuterium; Drug Monitoring; Drug Resistance; Humans; Hydrochlorothiazide; Hypertension; Limit of Detection; Male; Metoprolol; Middle Aged; Reproducibility of Results; Tandem Mass Spectrometry | 2019 |
Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs.
Topics: Albuminuria; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Canrenone; Humans; Hypertension; Inflammation; Insulin Resistance; Mineralocorticoid Receptor Antagonists; Spironolactone | 2014 |
Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.
Topics: Animals; Aorta; Arterial Pressure; Bufanolides; Canrenone; Cells, Cultured; Collagen Type I; Endothelin-1; Erythrocytes; Female; Fibrosis; Humans; Hypertension; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitroprusside; Pulse Wave Analysis; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Spironolactone; Vasodilator Agents | 2015 |
Polyuric-polydipsic syndrome in a pediatric case of non-glucocorticoid remediable familial hyperaldosteronism.
Topics: Age of Onset; Canrenone; Child, Preschool; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Genotype; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Antagonists; Mutation; Phenotype; Polydipsia; Polyuria; Syndrome | 2012 |
Influence of food intake on antihypertensive drugs: spironolactone.
Topics: Adult; Blood Pressure; Canrenone; Creatinine; Female; Food; Heart Rate; Humans; Hypertension; Male; Middle Aged; Potassium; Sodium; Spironolactone | 1983 |
Effect of canrenone and hydrochlorothiazide on the development of hypertension in rat models of genetic hypertension.
Topics: Animals; Biological Factors; Blood Pressure; Canrenone; Cardenolides; Digoxin; Disease Models, Animal; Hydrochlorothiazide; Hypertension; Rats; Rats, Inbred SHR; Saponins; Sodium-Potassium-Exchanging ATPase; Species Specificity | 1993 |
Effects of canrenone on RRM-sucrose hypertension in WKY.
Topics: Animals; Blood Pressure; Body Weight; Canrenone; Dietary Carbohydrates; Hypertension; Kidney; Nephrectomy; Rats; Rats, Inbred WKY; Sodium, Dietary; Sucrose | 1991 |
Effects of canrenone on blood pressure in rats with reduced renal mass.
Topics: Animals; Biological Transport, Active; Blood Pressure; Canrenone; Hypertension; Injections, Intramuscular; Male; Myocardium; Nephrectomy; Ouabain; Potassium; Pregnadienes; Rats; Rats, Inbred Strains; Renin; Sodium; Sodium-Potassium-Exchanging ATPase | 1990 |
Antihypertensive effect of canrenone in a model where endogenous ouabain-like factors are present.
Topics: Animals; Antihypertensive Agents; Blood Proteins; Canrenone; Cardenolides; Digoxin; Erythrocytes; Hypertension; Ion Channels; Male; Potassium; Pregnadienes; Rats; Rats, Inbred Strains; Saponins; Sodium; Sodium-Potassium-Exchanging ATPase | 1988 |
[Therapeutic response to canrenone of patients with essential hypertension as a function of sodium transport anomalies and ouabain sensitivity of erythrocytes].
Topics: Biological Transport; Canrenone; Erythrocytes; Female; Humans; Hypertension; Male; Middle Aged; Ouabain; Pregnadienes; Sodium Channels; Time Factors | 1989 |
Erythrocyte Na+, K+ pump inhibition after saline infusion in essentially hypertensive subjects: effects of canrenone administration.
Topics: Adult; Biological Transport, Active; Blood Pressure; Canrenone; Erythrocytes; Extracellular Space; Female; Humans; Hypertension; Male; Middle Aged; Ouabain; Potassium; Pregnadienes; Sodium; Sodium Chloride | 1989 |
Effects of saline infusion and canrenone on erythrocyte Na+,K+ pump activity.
Topics: Adult; Canrenone; Erythrocytes; Female; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Ouabain; Pregnadienes; Sodium; Sodium Chloride; Sodium-Potassium-Exchanging ATPase | 1988 |
[Canrenone: an effective antihypertensive in an experimental model of hypertension in which the active transport of sodium is diminished].
Topics: Animals; Antihypertensive Agents; Canrenone; Cell Membrane Permeability; Creatinine; Diuresis; Hypertension; Male; Natriuresis; Ouabain; Pregnadienes; Rats; Renin; Sodium; Urea | 1986 |